Humana issues positive coverage policy for percutaneous tibial nerve stimulation

November 4, 2013

Uroplasty announced that Humana, Inc. has written a positive coverage policy for percutaneous tibial nerve stimulation delivered via its Urgent PC Neuromodulation System.

Uroplasty announced that Humana, Inc. has written a positive coverage policy for percutaneous tibial nerve stimulation (PTNS) delivered via its Urgent PC Neuromodulation System.

Humana is the sixth largest private insurer in the United States, with approximately 8.9 million covered lives in 35 states, and is also the administrator for Tricare South and several Medicare Advantage plans.

Urgent PC is an office-based, minimally invasive treatment for overactive bladder and associated symptoms of urinary urgency, urinary frequency, and urge incontinence.

“This decision will now provide more patients access to the benefits of this clinically and cost-effective therapy,” said Darin Hammers of Uroplasty.

To get weekly news from the leading news source for urologists, subscribe to the Urology Times eNews.